Gut microbiota functional dysbiosis and obesity: mechanistic narrative review
This narrative review argues that diet-driven functional dysbiosis — not a specific microbial taxonomic signature — favors obesity and insulin resistance through reduced SCFA production, metabolic endotoxemia, and impaired enteroendocrine signaling, but provides no original effect estimates.
| Outcome | Grade | Direction | Effect | Studies |
|---|---|---|---|---|
| Short-chain fatty acid (SCFA) production | C | ▲ Favorable | narrative synthesis only; in the pooled effect size available | — |
| Microbial energy harvest | C | ▲ Favorable | 2-5% of energy demand on Western diets (single fermentation analysis study, in the IC reported) | 1 |
| Insulin resistance / glycemic regulation | C | ▲ Favorable | >500 circulating metabolites associated with impaired glucose regulation identified; ~1/3 modifiable by lifestyle; in the pooled OR or RR reported | 1 |
| Intestinal permeability and metabolic endotoxemia | D | ▲ Favorable | narrative synthesis from murine models; in the human effect size reported | — |
| GLP-1 and PYY secretion | D | ▲ Favorable | narrative synthesis; in the pooled effect size or IC available | — |
| Adiposity and BMI in children with obesity (inulin/fiber intervention) | C | ▲ Favorable | narrative synthesis of individual RCTs; in the pooled SMD or MD with IC reported | 2 |
| Adiposity after fecal microbiota transplantation in obese adolescents | C | ▲ Favorable | reduced adiposity and improved energy balance reported in single cited study; in the effect size or IC provided | 1 |
Context
Obesity and type 2 diabetes continue to rise globally, with lifestyle interventions showing limited long-term efficacy. The gut microbiota modulates energy harvest, intestinal barrier integrity, and hormonal signaling, representing a potential therapeutic target. This review synthesizes recent preclinical and clinical evidence on functional mechanisms linking dysbiosis to metabolic dysfunction.
What the study showed
Western diets remodel the gut microbiota within 24–48 h, depleting Roseburia, Eubacterium rectale, and Faecalibacterium while enriching bile-tolerant taxa. Microbial energy harvest accounts for only 2–5% of the caloric surplus on Western diets. A large-scale multiomics cohort identified >500 circulating metabolites associated with impaired glucose regulation, approximately one-third modifiable by lifestyle interventions. The review generates no pooled effect sizes or 95% CIs of its own.
How it was done
Unregistered narrative review (Current Opinion format) with no documented systematic search or formal risk-of-bias assessment. Integrates murine high-fat diet models, human observational studies, short-term dietary interventions, and multiomics cohort data. Total number of included studies and search period are not reported.
Effect magnitude
No primary effect size is calculated by this review. The sole quantitative magnitude estimate cited is microbial energy harvest contributing 2–5% of energy demand on Western diets, derived from a primary fermentation analysis study.
Limitations
Narrative design without systematic methodology precludes formal risk-of-bias assessment (AMSTAR-2 or ROBINS-I not applied). Evidence from murine models — which differ from humans in metabolic physiology and microbiota composition — is mixed with limited and heterogeneous clinical data. Causality for most described mechanisms remains unestablished in humans.
In clinical practice
Clinical practice should not be altered based solely on this narrative review. High-fiber diets show consistent effects on microbial profiles in cited primary studies, but consolidated clinical effect sizes for evidence-based prescription are absent. Microbiota-targeted interventions such as fecal microbiota transplantation for obesity remain experimental.
What is still missing
Adequately powered RCTs in humans are needed to quantify the independent contribution of specific microbial mechanisms (SCFA signaling, endotoxemia, bile acid signaling) on hard metabolic outcomes. Dose-response studies of dietary interventions on microbial function and insulin resistance in diverse populations are lacking.